LAS VEGAS, NV, Sept. 15, 2022 (GLOBE NEWSWIRE) -- PSYC Corporation (OTCPink: PSYC) (“PSYC” or the “Company”), a media leader focused on the emerging...
Numinus Updates On New Acquisition’s Integration And Provides Client Financing Options Numinus Wellness Inc. (OTCQX: NUMIF) recently acquired psychedelics...
Psychedelics are being talked about at major conferences all over the world, including South by SouthWest and Aspen Institute's Ideas Week, signaling a...
The article MindMed Retains its NASDAQ Listing was originally published on Microdose. Last month, MindMed announced a 1:15 reverse stock split. While...
Renowned academic journal praises company for development of psychoplastogens The post Delix gets recognized as leading start-up by Nature Biotechnology...
ATMA Journey Centers Inc. (“ATMA”), an Alberta-based company focused on the international delivery of innovative psychedelic-assisted therapy solutions,...
Source: Daniel Patrick Martin / Shutterstock.com MindMed (NASDAQ:MNMD) stock is in the news Wednesday after the psychedelic medicine company regained...
The article A Look at MAPS’ Phase 3 Trials was originally published on Microdose. The first of The Multidisciplinary Association for Psychedelic’s...
This trial will assess psilocybin efficacy in frontline healthcare professionals suffering from COVID-19-related mental wellness challenges. CALGARY, AB, Sept....
TORONTO, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery...